Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Male Pattern of Hair Loss, Androgenic Alopecia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01501617
What this trial is testing

Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
Histogen 56
Not applicableUnknownNCT03938948
What this trial is testing

Low Level Light Therapy (LLLT) for Hair Growth

Who this might be right for
Male Pattern BaldnessFemale Pattern Baldness
Awareable Technologies Inc 62
Testing effectiveness (Phase 2)Study completedNCT00418730
What this trial is testing

Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss

Who this might be right for
Androgenetic Alopecia
Neosil, Inc. 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT06527365
What this trial is testing

Safety and Efficacy of VDPHL01 in Males and Females With AGA

Who this might be right for
Androgenetic AlopeciaAGAMale Pattern Baldness
Veradermics, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT01451190
What this trial is testing

Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)

Who this might be right for
Androgenetic AlopeciaMale Pattern BaldnessFemale Pattern Baldness
Aderans Research Institute 88
Testing effectiveness (Phase 2)Looking for participantsNCT07317544
What this trial is testing

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia (AGA)Healthy Volunteers - Male and Female
Absci Pty Ltd. 227
Testing effectiveness (Phase 2)WithdrawnNCT03852992
What this trial is testing

Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia

Who this might be right for
Male Pattern Hair LossAndrogenetic AlopeciaMale Pattern Baldness
University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT01451177
What this trial is testing

Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)

Who this might be right for
Androgenetic AlopeciaMale Pattern BaldnessFemale Pattern Baldness
Aderans Research Institute 43
Testing effectiveness (Phase 2)Study completedNCT01548066
What this trial is testing

The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss

Who this might be right for
Androgenetic AlopeciaMale Pattern Baldness
Seoul National University Hospital 40
Not applicableStudy completedNCT02460289
What this trial is testing

Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia

Who this might be right for
Male Pattern of Hair Loss, Androgenic Alopecia
Galderma R&D 63
Not applicableStudy completedNCT00947505
What this trial is testing

Treatment of Androgenetic Alopecia in Males

Who this might be right for
Androgenetic AlopeciaHair LossMale Pattern Baldness
Lexington International, LLC 49
Post-approval studies (Phase 4)WithdrawnNCT05426629
What this trial is testing

Hydraderm for Androgenic Alopecia

Who this might be right for
Androgenic Alopecia
University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT01451047
What this trial is testing

Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)

Who this might be right for
Androgenetic AlopeciaMale Pattern BaldnessFemale Pattern Baldness
Aderans Research Institute 31
Testing effectiveness (Phase 2)Study completedNCT01669746
What this trial is testing

Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)

Who this might be right for
Androgenetic AlopeciaMale Pattern BaldnessFemale Pattern Baldness
Aderans Research Institute 34
Large-scale testing (Phase 3)Study completedNCT03753113
What this trial is testing

Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%

Who this might be right for
Androgenetic Alopecia
Farid Masoud 24
Testing effectiveness (Phase 2)Study completedNCT00965640
What this trial is testing

Treatment of Male Pattern Baldness With Botulinum Toxin

Who this might be right for
Male Pattern Baldness
The Crown Institute
Large-scale testing (Phase 3)Study completedNCT06924632
What this trial is testing

Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

Who this might be right for
Androgenetic AlopeciaMale Pattern Baldness
Samson Clinical Operations Pty Ltd 142
Not applicableStudy completedNCT00947219
What this trial is testing

Treatment of Androgenic Alopecia in Males

Who this might be right for
Androgenetic AlopeciaHair LossMale Pattern Baldness
Lexington International, LLC 79
Not applicableWithdrawnNCT05129254
What this trial is testing

Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
Montefiore Medical Center
Testing effectiveness (Phase 2)Study completedNCT01451073
What this trial is testing

Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013)

Who this might be right for
Androgenetic AlopeciaMale Pattern BaldnessFemale Pattern Baldness
Aderans Research Institute 33
Next Page